Zomedica Q2 EPS $(0.01) Down From $(0.01) YoY, Sales $6.13M Miss $6.26M Estimate
Portfolio Pulse from totan@benzinga.com
Zomedica (AMEX:ZOM) reported Q2 EPS of $(0.01), unchanged from last year, and sales of $6.13M, missing the $6.26M estimate. Sales increased by 1.84% YoY.
August 14, 2024 | 8:50 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Zomedica reported Q2 EPS of $(0.01), unchanged from last year, and sales of $6.13M, missing the $6.26M estimate. Sales increased by 1.84% YoY.
Zomedica's unchanged EPS and slight miss on sales estimates may lead to a negative short-term impact on the stock price. The YoY sales increase is positive but not enough to offset the miss.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100